[HTML][HTML] Periodontitis and its inflammatory changes linked to various systemic diseases: a review of its underlying mechanisms

R Bhuyan, SK Bhuyan, JN Mohanty, S Das, N Juliana… - Biomedicines, 2022 - mdpi.com
Periodontitis is a chronic inflammatory disease of the gums. The incidence of periodontitis is
increasing all over the world. In patients with periodontitis, there is gradual destruction of the …

A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: from molecular interactions to potential therapeutic targets

M Alimohammadi, P Rahimzadeh, R Khorrami… - … -Research and Practice, 2024 - Elsevier
Phosphatase and tensin homolog (PTEN), phosphatidylinositol 3-kinase (PI3K), and protein
kinase B (Akt) signaling pathways contribute to the development of several cancers …

Exosomal lncRNA NEAT1 inhibits NK-cell activity to promote multiple myeloma cell immune escape via an EZH2/PBX1 Axis

QM Wang, GY Lian, SM Sheng, J Xu… - Molecular Cancer …, 2024 - aacrjournals.org
Exosomal long noncoding RNAs (lncRNA) derived from cancer cells are implicated in
various processes, including cancer cell proliferation, metastasis, and immunomodulation …

Galectin-9–ligand axis: an emerging therapeutic target for multiple myeloma

RK Shil, NBB Mohammed, CJ Dimitroff - Frontiers in Immunology, 2024 - frontiersin.org
Galectin-9 (Gal-9) is a tandem-repeat galectin with diverse roles in immune homeostasis,
inflammation, malignancy, and autoimmune diseases. In cancer, Gal-9 displays variable …

Exosomal miRNAs in the tumor microenvironment of multiple myeloma

SD Alipoor, H Chang - Cells, 2023 - mdpi.com
Multiple myeloma (MM) is a malignancy of plasma cells in the bone marrow and is
characterized by the clonal proliferation of B-cells producing defective monoclonal …

Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics

MH Elbahoty, B Papineni, RS Samant - Clinical & Experimental Metastasis, 2024 - Springer
Multiple myeloma (MM) is a clinical disorder characterized by aberrant plasma cell growth in
the bone marrow microenvironment. Globally, the prevalence of MM has been steadily …

[HTML][HTML] The role of epigenetics in the development and progression of multiple myeloma

NH Ismail, A Mussa, NA Zakaria, MJ Al-Khreisat… - Biomedicines, 2022 - mdpi.com
Multiple myeloma (MM) is an exceptionally complicated and heterogeneous disease that is
caused by the abnormal proliferation of malignant monoclonal plasma cells initiated in the …

Exploring the mechanisms of drug-delivery by decorated ZnO nanoparticles through predictive ReaxFF molecular dynamics simulations

C Trouki, G Barcaro, S Monti - Nanoscale, 2022 - pubs.rsc.org
Herein, we study the assembling of a drug delivery nanocarrier through reactive molecular
dynamics simulations based on an appropriately tuned force field. First, we focus on the …

IL1B Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients

M Mazurek, A Szudy-Szczyrek, I Homa-Mlak, M Hus… - Cancers, 2024 - mdpi.com
Simple Summary According to the literature, 35–71% of multiple myeloma patients have
nutritional disorders. In the development of cachexia and malnutrition, the inflammatory …

Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma

Y Feng, J Huang, F Wang, Z Lin, H Luo, Q Li, X Wang… - Life Sciences, 2023 - Elsevier
Aims This study aimed to investigate the effect and mechanism of methylcrotonyl-CoA
carboxylase subunit 1 (MCCA) on multidrug resistance in multiple myeloma (MM). Materials …